Indications and uses
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
before using this product, read the enclosed consumer information leaflet for complete directions and information adults and children 12 years of age and over: applicators: insert 1 applicatorful into the vagina at bedtime for 7 nights in a row. Throw away applicator after use. external cream: squeeze a small amount of cream onto your fingertip. Apply the cream onto the itchy, irritated skin outside the vagina (vu...
do not use if seal over tube opening has been punctured do not purchase if carton is open store at 20°-25°C (68°-77°F)
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Miconazole nitrate 2% (100 mg in each applicatorful) | Vaginal antifungal |
| Miconazole nitrate 2% (external cream) | Vaginal antifungal |
For vaginal use only
Do not use if you have never had a vaginal yeast infection diagnosed by a doctor
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
call toll-free 877-666-4782
Distributed by: INSIGHT Pharmaceuticals, LLC., Trevose, PA 19053
7 DAY TREATMENT • CREAM
MONISTAT® 7
Miconazole Nitrate Vaginal Cream (2%) and Miconazole Nitrate Cream (2%)
(Miconazole Nitrate 100 mg per application)
VAGINAL ANTIFUNGAL
CURES MOST VAGINAL YEAST INFECTIONS
and relieves associated external itching and irritation
CLINICALLY PROVEN
MULTI-SYMPTOM RELIEF
COMBINATION PACK
TRIPLE ACTION
#1 DOCTOR
RECOMMENDED BRAND†
Net Wt. 1.59 oz. (45g) • 0.32 oz. (9g) tube

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63736-003-07 | 2020-06-29 | C162847 | 48780-1 | 9d75b9d0-5bcc-f424-e053-dadaa90a57ce | Monistat 7 Combination Pack Triple Action |
| 63736-003-07 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5bcc-f424-e053-dadaa90a57ce | Monistat 7 Combination Pack Triple Action |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Miconazole Nitrate | ACTIVE INGREDIENT | VW4H1CYW1K | 2 | |
| Miconazole | ACTIVE MOIETY | 7NNO0D7S5M | 2 | |
| BENZOIC ACID | INACTIVE INGREDIENT | 8SKN0B0MIM | 2 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| ISOPROPYL MYRISTATE | INACTIVE INGREDIENT | 0RE8K4LNJS | 2 | |
| POLYSORBATE 60 | INACTIVE INGREDIENT | CAL22UVI4M | 2 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| STEARYL ALCOHOL | INACTIVE INGREDIENT | 2KR89I4H1Y | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63736-003 | 63736-003-07 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TAMPON / VAGINAL | 62.1 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAMUSCULAR | 4000 mg | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | OINTMENT / TOPICAL | 569 mg | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | LOTION / TOPICAL | 1140 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / TOPICAL | 2.01 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / RECTAL | 90400 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL / TOPICAL | 29 mg | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | OINTMENT / TOPICAL | 2 %w/w | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET, EXTENDED RELEASE / ORAL | 244 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 63.4 %w/v | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 59 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / TOPICAL | 1800 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CREAM / VAGINAL | 200 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | INJECTION / INTRAVENOUS | 5 %w/v | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | CAPSULE, EXTENDED RELEASE / ORAL | 72 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / ORAL | ADJ PH | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | INJECTION, SOLUTION / INTRAMUSCULAR | 0.2 %w/v | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL / TOPICAL | 9.3 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUPPOSITORY / VAGINAL | 2 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CAPSULE, DELAYED RELEASE / ORAL | 59 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CONCENTRATE / ORAL | 7000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | POWDER / ORAL | 0.11 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, LIQUID FILLED / ORAL | 154 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUPPOSITORY / VAGINAL | 252 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | OIL / TOPICAL | 213 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | CREAM / VAGINAL | 50 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / DENTAL | 2 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM, AUGMENTED / TOPICAL | 8 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY / NASAL | 5 mg | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | EMULSION / ORAL | 20 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYRUP / ORAL | 5700 mg | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET / ORAL | 20 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | TABLET, FILM COATED / ORAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY, METERED / NASAL | 240 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TRANSDERMAL | 500 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | LOTION / TOPICAL | 0.2 %w/w | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYSTEM / TOPICAL | 4200 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL / TRANSDERMAL | 85 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / TOPICAL | 82 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / VAGINAL | 1225 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / RECTAL | 17 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | 3315 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / OPHTHALMIC | 0.6 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / RECTAL | 27 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | LIQUID / ORAL | 2 mg/1ml | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL / TOPICAL | 1.16 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | MOUTHWASH / BUCCAL | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / TOPICAL | 8 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAVENOUS | 16624 mg | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | SUSPENSION / TOPICAL | 2.85 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / DENTAL | NA | ||
| STEARYL ALCOHOL | STEARYL ALCOHOL | 2KR89I4H1Y | SUPPOSITORY / VAGINAL | 8.5 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N017450-002 | MONISTAT 7 | MICONAZOLE NITRATE | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N017450-002 | MONISTAT 7 | 2% | CREAM / VAGINAL | RLD, RS | 1991-02-15 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ab2cfe8d-2a1e-4f51-b578-b697d9b0ee4b | 18c41818-f0b5-4714-85d2-d1e9be7ce8fc | 2020-07-02 | Warnings | 18c41818-f0b5-4714-85d2-d1e9be7ce8fc |
Adverse event summaries are temporarily unavailable. Other product information remains available.